Management strategy for acute pancreatitis in the JPN Guidelines by Mayumi, Toshihiko et al.
J Hepatobiliary Pancreat Surg (2006) 13:61–67
DOI 10.1007/s00534-005-1053-5
Management strategy for acute pancreatitis in the JPN Guidelines
Toshihiko Mayumi1, Tadahiro Takada2,*, Yoshifumi Kawarada3, Koichi Hirata4, Masahiro Yoshida2,
Miho Sekimoto5, Masahiko Hirota6, Yasutoshi Kimura4, Kazunori Takeda7, Shuji Isaji8, Masaru Koizumi9,
Makoto Otsuki10,**, and Seiki Matsuno11,***
1Department of Emergency and Critical Care Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku,
Nagoya 466-8560, Japan
2Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan
3Ueno Municipal Hospital, Mie, Japan
4First Department of Surgery, Sapporo Medical University School of Medicine, Hokkaido, Japan
5Department of Healthcare Economics and Quality Management, Kyoto University Graduate School of Medicine, Kyoto, Japan
6Department of Gastroenterological Surgery, Kumamoto University Graduate School of Medical Science, Kumamoto, Japan
7Department of Surgery, National Hospital Organization Sendai Medical Center, Sendai, Japan
8Department of Hepatobiliary Pancreatic Surgery and Breast Surgery, Mie University Graduate School of Medicine, Mie, Japan
9Ohara Medical Center Hospital, Fukushima, Japan
10Department of Gastroenterology and Metabolism, University of Occupational and Environmental Health, Japan, School of Medicine,
Kitakyushu, Japan
11Division of Gastroenterological Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan
cases, because it seems to decrease morbidity. Necrosectomy
is performed when necrotizing pancreatitis is complicated
by infection. In this case, continuous closed lavage or open
drainage (planned necrosectomy) should be the selected pro-
cedure. Pancreatic abscesses are treated by surgical or percu-
taneous drainage. Emergency endoscopic procedures are
given priority over other methods of management in patients
with acute gallstone-associated pancreatitis, patients sus-
pected of having bile duct obstruction, and patients with acute
gallstone pancreatitis complicated by cholangitis. These strat-
egies for the management of acute pancreatitis are shown in
the algorithm in this article.
Key  words  Acute pancreatitis · Algorithm · Guidelines ·
Decision-making · Evidence-based medicine
Clinical questions
CQ1. How is acute pancreatitis diagnosed?
CQ2. What  is  the  basic  initial  management  of
acute pancreatitis?
CQ3. Is  an  evaluation  of  the  etiology  of  acute
pancreatitis  necessary  in  the  initial
management?
CQ4. Why  is  a  severity  assessment  of  acute
pancreatitis  necessary  in  the  initial
management?
CQ5. When should patients with acute pancreati-
tis be transferred to a specialist hospital?
CQ6. Why  are  contrast-enhanced  CT  scanning
and MRI used in the management of acute
pancreatitis?
Abstract The diagnosis of acute pancreatitis is based on the
following ﬁndings: (1) acute attacks of abdominal pain and
tenderness in the epigastric region, (2) elevated blood levels
of pancreatic enzymes, and (3) abnormal diagnostic imaging
ﬁndings in the pancreas associated with acute pancreatitis. In
Japan, in accordance with criteria established by the Japanese
Ministry of Health, Labour, and Welfare, the severity of acute
pancreatitis is assessed based on the clinical signs, hematologi-
cal ﬁndings, and imaging ﬁndings, including abdominal con-
trast-enhanced computed tomography (CT) and magnetic
resonance imaging (MRI). Severity must be re-evaluated, es-
pecially in the period 24 to 48h after the onset of acute pancre-
atitis, because even cases diagnosed as mild or moderate in the
early stage may rapidly progress to severe. Management is
selected according to the severity of acute pancreatitis, but it is
imperative that an adequate infusion volume, vital-sign moni-
toring, and pain relief be instituted immediately after diagno-
sis in every patient. Patients with severe cases are treated with
broad-spectrum antimicrobial agents, a continuous high-dose
protease inhibitor, and continuous intraarterial infusion of
protease inhibitors and antimicrobial agents; continuous
hemodiaﬁltration may also be used to manage patients with
severe cases. Whenever possible, transjejunal enteral nutri-
tion should be administered, even in patients with severe
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CQ7. What  is  important  in  the  critical  care  of
severe acute pancreatitis?
CQ8. What are some optional therapies for severe
acute pancreatitis?
CQ9. How can the complications of acute pancre-
atitis be assessed?
CQ10. Is  the  endoscopic  approach  beneﬁcial  in
the  treatment  of  acute  gallstone-induced
pancreatitis?
CQ11. Is  one-stage  cholecystectomy  followed  by
common  bile  duct  (CBD)  clearance  safer
and  more  effective  than  endoscopic
procedures?
CQ12. When should laparoscopic cholecystectomy
be  undertaken  in  patients  with  gallstone
pancreatitis?
Basic medical treatment policy (see ﬂowchart in Fig. 1)
Evidence-based clinical practice guidelines for acute
pancreatitis were created a few years ago,1 but several
modiﬁcations have been made, thanks to consensus
conferences and a great deal of feedback. The ﬂowchart
in Fig. 1 illustrates the details of the current Guidelines
according to the procedures and the timing of their
performance. A brief explanation of each point is pro-
vided in this article, but please refer to the correspond-
ing text in the Guidelines for details.2–9
Fig. 1. Basic treatment policy. CT, computed tomographyT. Mayumi et al.: Management strategy for acute pancreatitis in JPN Guidelines 63
Diagnosis of acute pancreatitis5
Clinical question (CQ) 1. How is acute pancreatitis
diagnosed?
Acute pancreatitis is diagnosed based on a
comprehensive assessment of the clinical manifesta-
tions, including elevated extrapancreatic enzyme levels
and imaging ﬁndings in the pancreas (Recommenda-
tion A).
In 1990, the Research Group for Intractable Diseases
and Refractory Pancreatic Diseases, which was spon-
sored by the then Japanese Ministry of Health and
Welfare, established the criteria for diagnosing acute
pancreatitis in Japan (Table 1), and these criteria have
been used as the gold standard ever since. Acute pan-
creatitis must be differentiated from other conditions.
Acute abdomen, gastrointestinal perforation, acute
cholecystitis, ileus, mesenteric artery occlusion, and
acute aortic dissection must all be ruled out.
Basic management7
CQ2. What is the basic initial management of acute
pancreatitis?
Adequate ﬂuid infusion (Recommendation A), vital-
sign monitoring, and respiratory and cardiovascular
management should be performed in the early stage,
immediately after diagnosis is made. Research done in
Japan in 2004 reported the infusion volume on the ﬁrst
day in hospital to be less than 3500ml in 41 (61.2%) of 67
patients who later died. An adequate infusion volume
should be given in the early stage, because some cases
diagnosed initially as mild can rapidly progress to severe.
Pain relief with analgesics is necessary in patients with
acute pancreatitis with associated pain, because the pain
may cause mental distress and adversely impact the course
of treatment by, for example, causing tachypnea. Gastric
suction with a nasogastric tube (Recommendation D) is
unnecessary in mild or moderate cases, unless acute
pancreatitis is associated with paralytic ileus or frequent
nausea/vomiting. H2 blockers are also unnecessary unless
a stress ulcer develops (Recommendation D).
Identiﬁcation of etiological factors in acute pancreatitis5
CQ3. Is an evaluation of the etiology of acute pan-
creatitis necessary in initial management?
Etiological factors in acute pancreatitis should be
identiﬁed promptly and accurately, because, together
with the severity assessment, they have a major impact
on the treatment policy. It is particularly important to
differentiate acute gallstone-associated pancreatitis
from acute alcoholic pancreatitis, because the two
manifestations require different management proce-
dures, with the former including management of the
bile duct system (Recommendation A)
Because different types of acute pancreatitis have dif-
ferent treatments, each patient should be evaluated im-
mediately for the presence of the following abnormal
ﬁndings related to etiology: leaking hepatic enzymes
(alanine aminotransferase [ALT] and aspartate amino-
transferase [AST]) and biliary system enzymes (alkaline
phosphatase [ALP], lactate dehydrogerase [LDH], and
guanosine triphosphate [GTP]), investigated using
blood biochemistry studies; and cholecystocholedocho-
lithiasis and cholangiectasis, investigated using ultra-
sonography (US) examination. Biliary sand and ﬁne
gallbladder stones may be found later, even in patients
in whom cholecystocholedocholithiasis is not detectable
in the acute stage. Therefore, patients should be repeat-
edly examined for cholecystocholedocholithiasis, even
after the acute stage.
Assessment of the severity of acute pancreatitis6
CQ4. Why is a severity assessment of acute pancre-
atitis necessary in the initial management?
Severity assessment ensures appropriate management
(Recommendation A). Because mild acute pancreatitis
in the early stage may rapidly progress to severe pan-
creatitis, continuous evaluation is necessary, particu-
larly within the ﬁrst 3 days of onset
Severity assessment according to severity scoring sys-
tems (JPN score, Acute Physiology and Chronic Health
Table 1. Criteria for the clinical diagnosis of acute pancreatitisa
1. Attack of acute abdominal pain and tenderness in the upper abdomen
2. Increased levels of pancreatic enzymes in blood, urine, or ascitesb
3. Abnormal imaging ﬁndings in pancreas associated with acute pancreatitis
Patients having two or more of the above three criteria are diagnosed with acute pancreatitis,
excluding other pancreatic diseases and acute abdomen. However, an acute episode of chronic
pancreatitis is diagnosed as acute pancreatitis. Cases conﬁrmed as acute pancreatitis by surgery or
autopsy should carry a supplement note
aResearch Group for Intractable Diseases and Refractory Pancreatic Diseases sponsored by the
their Japanese Ministry of Health and Welfare in 1990
bMeasurement of highly speciﬁc pancreatic enzymes (such as P-amylase) is recommended64 T. Mayumi et al.: Management strategy for acute pancreatitis in JPN Guidelines
Evaluation [APACHE] II score) is important in decid-
ing treatment policy and judging whether transfer to a
specialist unit is necessary (Recommendation A). Se-
verity assessment on the basis of the JPN score is recom-
mended in Japan.
Diagnosis of acute pancreatitis should be followed by
a severity assessment and a management strategy ap-
propriate to the level of severity. The Japanese criteria
and scoring system allow sequential scoring and are
useful for deciding on treatment policy. Use of this sys-
tem has improved the survival rate.
Because even mild to moderate cases may progress
to severe during the early stage, particularly within
72h of onset, severity should be re-evaluated within
24 to 48h of onset and again within 48 to 72h of
onset.
The outcome for patients whose acute pancreatitis
progressed from mild or moderate to severe was found
to be poor in a Japanese study done in 2004.
Transfer to advanced specialist medical institutions6
CQ5. When should patients with acute pancreatitis
be transferred to a specialist hospital?
A JNP score of 2 or more is the criterion for transfer
(Recommendation A). It is desirable to transfer pa-
tients with severe acute pancreatitis to a medical insti-
tution where monitoring and systemic management are
available
In principle, acute pancreatitis should be treated on an
inpatient basis. The criteria for evaluating the severity
of acute pancreatitis established by the Japanese Minis-
try of Health, Labour, and Welfare6 (JMHLW Criteria)
have been used widely in Japan to assess the severity of
acute pancreatitis. It is desirable to transfer patients
diagnosed with severe pancreatitis, based on these crite-
ria, to a medical institution with fulltime surgeons and
physicians specializing in gastroenterology. In view of
their signiﬁcantly higher mortality rate, it has been re-
ported (Level 3b) [89] that patients with a severity score
of 8 or more according to the JMHLW Criteria or an
APACHE II score of 13 or more within the ﬁrst 24 to
48h after onset should be transferred, preferably to an
institution where they can be cared for by fulltime phy-
sicians who specialize in intensive care, endoscopic
treatment, radiological intervention, and cholangio-
pancreatic surgery. Patients with cases diagnosed as
moderate also need to receive an adequate volume of
ﬂuid infusion, meticulous monitoring of their clinical
course, and assessment of indications for transfer to
advanced medical institutions, because their acute
pancreatitis may progress to severe pancreatitis. The
decision to transfer a patient should be made carefully,
taking into consideration the potential impact of a long
trip on the patient’s condition.
It is desirable to transfer a patient with severe acute
pancreatitis (JMHLW criteria severity score of 2 or
more) to a medical institution where monitoring and
systemic management are available and where the pa-
tient will receive an adequate medical examination.
Contrast-enhanced computed tomography (CT)5,7
CQ6. Why are contrast-enhanced CT scanning and
magnetic resonance imaging (MRI) used in the man-
agement of acute pancreatitis?
Contrast-enhanced CT scanning and magnetic reso-
nance imaging (MRI) are essential for severity assess-
ment and for making decisions about management
policy (Recommendation A).
The presence and extent of pancreatic necrosis and the
extent of inﬂammatory change are correlated with
severity. Contrast-enhanced CT or contrast-enhanced
MRI is required to make a deﬁnite judgment regarding
the presence and extent of pancreatic necrosis. How-
ever, it should be noted that contrast media may cause
adverse reactions.
The presence of pancreatic necrosis and the extent of
inﬂammatory change are closely correlated with various
complications and the mortality rate (Levels 1b–3b)
[57–59] and may inﬂuence the selection of management
methods, including the administration of prophylactic
antimicrobial agents and intraarterial infusion therapy.
Inﬂammatory change in the peripancreatic tissue can be
evaluated by plain CT, but, because it is usually difﬁcult
to diagnose pancreatic necrosis, contrast-enhanced CT
scanning (Level 1c) [60] is required to identify and
determine the extent of pancreatic necrosis. However,
while one study has shown that the use of contrast me-
dium does not exacerbate the pathological conditions of
pancreatitis (Level 2b) [61], another has shown that its
use exacerbates pancreatitis (Level 2b) [62] and that the
use of contrast medium may also exacerbate nephropa-
thy, thereby complicating severe acute pancreatitis. In
view of the above ﬁndings, contrast-enhanced CT
should be performed only when the value of the infor-
mation to be obtained exceeds disadvantages such as
impairment of renal function or an allergic reaction.
The possible advantages of contrast-enhanced CT are
the visualization of pancreatic necrosis, the usefulness
of the ﬁndings in assessing the need for surgical man-
agement and drainage, and occasional visualization of
false aneurysms, which may provide an opportunity to
prevent their rupture.T. Mayumi et al.: Management strategy for acute pancreatitis in JPN Guidelines 65
Intensive care7
CQ7. What is important in the critical care of severe
acute pancreatitis?
Appropriate infusion management, strict cardiovascu-
lar and respiratory management, and the prevention
and management of organ failure and infection are all
important
Acute pancreatitis requires the basic management strat-
egies that are described above. In critical cases, oxygen
administration, artiﬁcial respiration (ventilation), and
management of electrolytes and blood sugar should be
performed as required.
Continuous intravenous infusion of massive doses of
protease inhibitors may decrease the incidence of com-
plications in severe acute pancreatitis (Recommenda-
tion B).
Because transjejunal enteral nutrition is superior to
total parenteral nutrition in the nutritional management
of pancreatitis, enteral nutrition should be administered
unless there are manifestations of ileus (Recommenda-
tion A).
The prophylactic use of antimicrobial agents is
unnecessary in mild and moderate cases, but the
administration of broad-spectrum antimicrobial agents
with good penetration into pancreatic tissue is required
in severe cases, as this will help prevent infection (Rec-
ommendation A).
Optional procedures for severe cases7
CQ8. What are some optional therapies for severe
acute pancreatitis?
Blood puriﬁcation therapy is used in the management
of severe acute pancreatitis, and continuous regional
pancreatic-arterial infusion of protease inhibitors/
antimicrobial agents is used in the management of
necrotizing pancreatitis (Recommendation C)
Selective digestive decontamination (SDD) can be used
in severe cases, but, because there has been only one
randomized controlled trial (RCT) of SDD (with a lim-
ited number of patients), it remains unclear whether
systemic administration of antimicrobiotics or the com-
bined use of the systemic administration of antimicrobio-
tics and SDD is more efﬁcacious (Recommendation C).
Blood puriﬁcation, particularly continuous hemo-
diaﬁltration (CHDF), may prevent severe acute pan-
creatitis from progressing to multiple organ failure
(Recommendation C). Continuous regional pancreatic-
arterial infusion of protease inhibitors/antimicrobial
agents may decrease the mortality rate and the inci-
dence of infectious complications in patients with ne-
crotizing pancreatitis (Recommendation C). However,
the efﬁcacy of blood puriﬁcation and pancreatic-arterial
infusion therapy will remain uncertain until conﬁrmed
by a high quality RCT. An RCT of continuous pancre-
atic-arterial infusion is currently underway.
Assessing the complications of acute pancreatitis8
CQ9. How can the complications of acute pancreati-
tis be assessed?
Patients should be examined for complications of acute
pancreatitis, i.e., infected pancreatic necrosis and pan-
creatic abscess, by abdominal ultrasonography (US)
and abdominal CT scanning (Recommendation A)
Other recommendations are as follows:
(1) CT- or US-guided ﬁne-needle aspiration biopsy
(FNAB) should be performed when infected pan-
creatic necrosis is suspected (Recommendation
A).
(2) Infected pancreatic necrosis with signs of sepsis is
an indication for surgical intervention (Recom-
mendation B).
(3) Noninfected pancreatic necrosis is usually man-
aged conservatively, in general, but those cases in
which the patient’s condition does not improve (or
visceral disorders progress and infection cannot be
ruled out) are candidates for surgical intervention
(Recommendation B).
(4) Early surgery is not recommended for necrotizing
pancreatitis in the absence of speciﬁc indications
(Recommendation B).
(5) Necrosectomy is recommended for the surgical
management of infected pancreatic necrosis
(Recommendation A).
(6) Simple drainage should be avoided as a method of
post-necrosectomy management, and continuous
closed lavage or open drainage (planned
necrosectomy) should be selected instead (Rec-
ommendation B).
(7) Pancreatic abscess should be managed by
surgical or percutaneous drainage (Recommenda-
tion C).
(8) Pancreatic abscesses that do not respond clinically
to percutaneous drainage should be immediately
treated by surgical drainage (Recommendation
B).
(9) Symptomatic cases, acute pancreatitis cases with
complications, and pancreatic pseudocysts whose
diameter is increasing should be treated by drain-
age (Recommendation A).
(10) Surgical intervention should be selected for those
pancreatic pseudocysts that do not tend toward
improvement in response to percutaneous or en-
doscopic drainage (Recommendation A).66 T. Mayumi et al.: Management strategy for acute pancreatitis in JPN Guidelines
Management policy for gallstone pancreatitis (Fig. 2)9
CQ10. Is the endoscopic approach beneﬁcial in the
treatment of acute gallstone-induced pancreatitis?
Emergency endoscopic procedures should be given pri-
ority in patients with acute gallstone-associated pan-
creatitis with suspected bile duct obstruction and in
cases complicated by cholangitis (Recommendation
A)
When a diagnosis of gallstone pancreatitis is made
(based on imaging and blood biochemistry ﬁndings
performed immediately after medical examination),
the patient should be examined for cholangitis and
transit disorders in the biliary tract, and severity should
be assessed. If the above complications are present,
emergency endoscopic procedures (biliary calculus
removal and common bile duct drainage) are used,
in combination with the management of severe
pancreatitis.
When these procedures cannot be used, percutane-
ous biliary duct drainage or surgical decompression is
performed, as needed. Whether these drainage proce-
dures are selected depends on the patient’s condition
Fig. 2. Management policy for acute biliary pancreatitis. ERC, endoscopic retrograde cholargiograhy; ES, endoscopic sphincter-
otomy; ENBD, endoscopic nasobiliary drainageT. Mayumi et al.: Management strategy for acute pancreatitis in JPN Guidelines 67
and the availability of specialist medical professionals
and the appropriate institution.
Emergency endoscopic procedures (endoscopic ret-
rograde cholangiography [ERC] – endoscopic sphinc-
terotomy [ES], endoscopic papillary balloon dilatation
[EPBD], endoscopic nasobiliary drainage [ENBD], and
stenting) are designed to remove biliary calculi and to
drain the biliary tract, and they can often relieve any
occlusion of the pancreatic duct.
It is important to transfer patients to an advanced
specialist medical institution if they are not able to un-
dergo the needed procedures at the institution where
they are being treated.
CQ11. Is one-stage cholecystectomy followed by
common bile duct (CBD) clearance safer and more
effective than endoscopic procedures?
Open choledochotomy or sphincterotomy (surgical re-
moval of CBD stones) is recommended (Recommenda-
tion D)
An RCT (Level 1b) [45] that compared patients who
had early surgery (within 72h after hospitalization) and
those who had delayed surgery found that there was no
difference in the incidence of complications (8.3% vs
10.3%) or mortality (2.8% vs 6.9%) between the early
group and the delayed group. Another RCT (Level 1b)
[46] revealed that early surgery (within 48h of hospital
admission) was followed by a signiﬁcantly higher inci-
dence of complications (30.1% vs 5.1%) and mortality
(15.1% vs 2.4%) than was delayed surgery (from 48h
onward after hospital admission). Because endoscopic
procedures such as ERC+ES can now be performed
safely, surgical removal or drainage of gallstones in the
acute stage is not recommended if these endoscopic
procedures are indicated.
CQ12. When should laparoscopic cholecystectomy
be undertaken in patients with gallstone
pancreatitis?
Laparoscopic cholecystectomy during the same hospi-
tal stay as the initial treatment is recommended for
patients with mild gallstone pancreatitis without com-
plications  (Recommendation B). Choledochotomy
and/or choledocholithotomy are performed when
deemed necessary
In recent years laparoscopic operations have been in-
creasingly used to treat many patients with gallstone-
induced pancreatitis. According to the results of
prospective cohort studies (Levels 1b–2c) [16–21], the
percentage of patients in whom laparoscopic cholecys-
tectomy was completed was 94.5% (range, 79% to
100%), the incidence of complications was 5.5% (range,
0% to 10%), and the mortality rate was 0.4% (range,
0% to 2.5%), suggesting that the outcome of
laparoscopic operations is equal to or better than that of
laparotomy. Based on the above data, laparoscopic
cholecystectomy may also be used in the management
of mild gallstone pancreatitis.
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